CONFLICTING results have recently been reported by various groups of workers regarding the change in sensitivity to bleomycin (BLM) which occurs as cultured mammalian cells pass from exponential growth into plateau phase. Using various Chinese hamster cell lines, Ray et al. (1973) and Barranco, Novak and Humphrey (1973) have shown an increased sensitivity to the drug, whereas Mauro et al. (1974) have shown reduced sensitivity. In our own studies using the EMT6 mouse tumour cell line in culture (Twentyman and Bleehen, 1973) we originally found a reduced sensitivity in plateau phase, but more recently (Twentyman and Bleehen, 1975) we have demonstrated that when the cells have been in plateau phase for more than 10 days, the BLM sensitivity is greater than that seen during exponential growth.
Furthermore, it appears that delayed subculture following BLM treatment of cells in vitro Twentyman and Bleehen, unpublished) or from a solid tumour results in a reduction in the cell killing effect of the drug. One explanation for the finding is repair of " potentially lethal damage " similar to that which has been found following radiation treatment both in vitro (Hahn and Little, 1972) and in vivo (Little et al., 1973) .
In a study of BCNU response both in vitro and in vivo, Hagemann, Schenken and Lesher (1973) 
MATERIALS AND METHODS
The EMT6 cell line may be grown either in vivo as a solid tumour or in vitro as a monolayer (Rockwell, Kallman and Fajardo, 1972) . In addition, assay of cell survival following treatment in vivo may be assayed by in vitro plating .
Tumour transplantation was carried out by the intradermal injection of 4 x 104 EMT6 cells which had been in culture for about 20 days after being taken from the previous animal tumour generation. At 8 or 9, 15, 22 or 35 days following transplantation, groups of 3 tumour bearing mice were treated with BLM. The drug was injected intra-peritoneally in a volume of 0 5 ml of normal saline either 2 or 24 h before killing the animal and subsequent remnoval of the tumour.
Tumours were removed aseptically immediately after killing the animals. The tumours from each group of 3 animals were minced together in a glass petri dish using fine curved scissors. A small volume of Hank's solution was added, and the tumour fragments were washed into a glass universal containing 10 ml of Hank's solution with 0-1% added trypsin and a magnetic followTer, the entire assembly being warmed to 37°C. The universal was then placed on a magnetic stirrer for 20 min at room temperature. At the end of this time, the contents were filtered through a P.T.F.E. funnel containing cotton gauze into a plastic universal which wN-as then centrifuged at 1000 rev/min for 10 min at 4°C. At the end of this time, the supernatant was discarded, the cells resuspended in comnplete growth medium and placed on ice. A count of morphologically viable cells under phase contrast was then carried out using a haemacytoineter, dilutions wNere made and the cells w-ere plated.
The foregoing method was slightly modified for large (22 and 35 day) tumours.
'lthese tumnours, after mincing, were washed into glass flasks containing 150 ml of Hanks' solution plus 0.10/ trypsin at 37°C. The solution wNas then stirred at room temperature on a motor with a razor blade attached for 20 min. Following filtration, centrifugation was carried out in glass centrifuge vessels. 
Bleomycin response
The response to bleomycin of tumours of various sizes shows essentially the same picture quantitatively and qualitatively including the spread of data. The figure shows the data for the 15-day old tumour. For each tumour size, the response curve is biphasic, with an initial fall to a surviving fraction of about 10% being achieved by a dose of 1 mg/kg and a much less steep fall above this dose. The lines drawn on the graph lie approximately through the mean surviving value obtained at each dose. The spread of individual values at each dose is, however, considerable.
When tumour removal and plating were delayed until 24 h after bleomycin administration, the drug was found to have had little or no effect on cell survival at any of the tumour sizes. (Twentyman and Bleehen, 1975) Little et al. (1973) for radiation damage when delayed subculture was found to result in more enhancement of survival in large than in small NCTC solid tumours. In this situation, however, the amount of repair is small compared with that following BLM treatment.
It is important to remember that even the smallest tumours which we have studied (approximately 7 mm3) represent a late stage of the growth of a solid tumour from an inoculum of a few cells. It is very possible that quite different responses to BLM would be shown by solid tumours at earlier stages of growth. It is our intention to extend our studies to such tumours using indirect techniques of survival assay.
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